Accendra Health Finalizes $1.5 Billion Debt Exchange and New Note Issuance
Summary
Accendra Health successfully completed its major debt exchange offers and new money offering, restructuring over $1 billion in debt and issuing new notes with high participation rates.
Key Events
-
Debt Exchange Offers Expire
The company announced the expiration and final results of its offers to exchange 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030.
-
High Participation Rate Achieved
Approximately 99.9% of 2029 Notes ($478.3 million) and 99.2% of 2030 Notes ($548.0 million) were validly tendered and accepted.
-
New Notes Issued
Accendra Health issued $213.0 million in First Lien Notes and $698.1 million in Second Lien Notes in exchange for existing debt, plus an additional $326.25 million in First Lien Notes for new money, totaling $539.25 million in First Lien Notes.
-
Capital Structure Overhaul Completed
This filing confirms the final settlement of a comprehensive balance sheet optimization transaction exceeding $1.5 billion, significantly improving the company's financial position.
Analysis
This 8-K announces the successful expiration and final settlement of Accendra Health's comprehensive debt exchange offers and new money offering. The company achieved near-full participation (over 99%) in exchanging its existing senior notes for new First Lien and Second Lien Notes, and successfully issued $326.25 million in new First Lien Notes. This marks the completion of a critical balance sheet optimization transaction exceeding $1.5 billion, significantly improving the company's capital structure and securing its financial runway.
At the time of this filing, ACH was trading at $3.17 on NYSE in the Trade & Services sector, with a market capitalization of approximately $242.8M. The 52-week trading range was $1.84 to $9.55. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.